A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)
Clinical trial NCT01432730 · COMPLETED
Trial details
- NCT number
- NCT01432730
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-22
- Primary completion
- 2013-02-07
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.